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Abstract 
Aim: The goal of this study was to establish the level of awareness amongst pregnant women in terms of preparation for an oral 
glucose tolerance test (oGTT), compare the results of two waves of data collection, and identify the most frequent preanalytical 
mistakes made in connection to the oGTT. Design: Comparison of 2 cross-sectional studies. Methods: From 2013–2017 two 
independent questionnaire studies were performed on a total of 477 pregnant women in the Olomouc and Zlín regions. A total 
of 225 respondents took part in Study 1 (2013–2014), and a total of 252 in Study 2 (2016–2017). Acquired data was analysed 
using descriptive statistics focused on the substantive significance of the results, as well as inference statistics. Results: Based 
on the sum index, the overall level of awareness had increased slightly amongst the women in Study 2 (by 0.41 points out of 5), 
Cohen’s d = 0.3 suggests the effect was only mediocre. Fifteen erroneous processes were found. However, these had a decreasing 
trend once the guidelines had been unified. Conclusion: A more reliable performance of the oGTT in certified laboratories was 
declared by the respondents in Study 2. The level of awareness, and checking on their adherence to the regime before and during 
the course of measuring the oGTT in pregnant women was still inadequate. It is necessary to improve pregnant women’s 
awareness of how to perform the oGTT correctly to ensure the least possible distortion of the results. 
Keywords: oGTT, performance, preparation and awareness, recommended procedure. 
 
Introduction 
Gestational diabetes mellitus (GDM) is a disorder in 
the metabolism of carbohydrates, fats, and proteins, 
which usually occurs between the second and third 
trimesters of pregnancy, resolves during the course 
of the postpartum period, and sometimes can recur 
(Anderlová et al., 2014a; Bakiner et al., 2013). GDM 
prevalence ranges from 9.6%–24% (American 
Diabetes Association, 2011; Anderlová et al., 2014b; 
Franeková & Jabor, 2010; Krejčí et al., 2019) and 
increases with the age of the pregnant woman. For 
women over 35 years of age, it reaches 19%–20% and 
copies the increase in numbers of those overweight 
and suffering obesity and diabetes in economically 
advanced countries (Krejčí et al., 2019; Metzger et al., 
2008). 
Timely treatment of GDM reduces the risk of 
pregnancy and perinatal complications. A mere 
lifestyle change can suffice in achieving good GDM 
compensation for up to 90% of women (Andělová et 
al., 2018; Landon et al., 2009; Negrato & Gomes, 
2013). It is important, however, that women with  
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GDM are diagnosed early. The diagnostic criteria for 
GDM applied in the Czech Republic (CR) until 2015 
were based on the criteria for glucose tolerance 
disorder in the general population (Andělová, 2013). 
GDM screening methods were inconsistent not just in 
the CR, but throughout the world. The IADPSG 
(International Association of Diabetes and Pregnancy 
Study Groups) only published new criteria for GDM 
diagnosis in 2010 on the basis of the results of the 
HAPO (Hyperglycemia and Adverse Pregnancy 
Outcome) multicentre study, and these were gradually 
adopted by professional organisations in many 
countries and by international institutions 
(the International Association of Diabetes and 
Pregnancy Study Groups, 2010; the HAPO Study 
Cooperative Research Group, 2008; the HAPO Study 
Cooperative Research Group, 2009; the World Health 
Organization, 2013). In the CR, the new diagnostic 
criteria were gradually adopted in 2014–2015, first by 
the Czech Medical Association of J. E. Purkyně 
(“CzMA JEP”) Czech Diabetes Society and the CzMA 
JEP Czech Society of Clinical Biochemistry, then later 
also by the CzMA JEP Czech Gynecological and 
Obstetrical Society – CGOS (Andělová et al., 2018; 
Čechurová & Andělová, 2014; Friedecký et al., 2016). 
The most recent updated version was published as a 
summary document alongside recommended practice
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for gynaecological, diabetological, and neonatal care 
in 2018 and 2019 (Andělová et al., 2018; CGOS 
CzMA JEP, 2019; Krejčí et al., 2018). We have 
compared 2 cross-sectional studies (Study 1 was 
conducted prior to the unification of guidelines, Study 
2 afterwards) aimed at finding whether the unification 
of guidelines in the Czech Republic had a positive 
influence on the performance of the oGTT (oral 
glucose tolerance test). 
Since 2009, automatic GDM screening for all pregnant 
women has been indicated in the CR, except for 
women known to have a pre-gestational glucose 
metabolism disorder. The pregnant woman’s own 
gynaecologist refers them for the examination, which 
is secured by a certified laboratory. The patients’ 
blood sugar level is determined from venous blood 
(Friedecký et al., 2016). Screening is carried out in two 
phases. The first phase involves determining blood 
sugar level on an empty stomach from venous blood, 
and this should be done by the 14th week of pregnancy. 
The second phase – actual performance of the oGTT, 
takes place between the 24th and 28th week (Andělová 
et al., 2018; Čechurová & Andělová, 2014). The 
pregnant woman should observe her standard dietary 
regime (she should not limit carbohydrate intake), and 
the day before the oGTT she should avoid excess 
physical exertion and ensure she does not smoke. The 
actual oGTT is performed by determining three blood 
sugar level values from venous blood (glycaemia on 
an empty stomach, and at 60 and 120 min. after 
drinking 75 g of glucose). The first sample is taken in 
the morning after at least 8 hours of fasting (only water 
can be consumed). If a blood sugar level of ≥ 5.1 
mmol/l is found, no further tests are made and 
following instruction, the woman is invited to return 
for another blood test on an empty stomach on another 
day. If normal blood sugar levels are ascertained, the 
woman drinks a solution of 75 g glucose dissolved 
in 300 ml water within a 5–10 minute period. 
The second venous blood sample is taken after 60 
minutes, and the third after 120 minutes. Each blood 
sugar level must be ascertained by the standard 
method within 1 hour from collection at the latest. 
During the entire test period, the woman must remain 
at physical rest within the laboratory’s waiting room. 
She must not smoke prior to or during the test. Regular 
doses of anti-insulin medication (in particular 
hydrocortisone, thyroxine, beta-sympathomimetic 
drugs) can only be used on the day of the test after it 
is completed. The test should not be performed during 
a period of acute illness (viral or other infectious 
disease, injury, etc.). If blood sugar level on an empty 
stomach is repeatedly ≥ 5.1 mmol/l, at 60 min. ≥ 10.0 
mmol/l, at 120 min. ≥ 8.5 mmol/l – this means GDM 
is present and the woman is referred to diabetology. 
Care for a pregnant woman with apparent diabetes is 
then the same as care for a pregnant woman with 
pregestational diabetes (Friedecký et al., 2016). 
Determining blood sugar level by glucose tolerance 
(oGTT) may be affected by some level of imprecision 
in measuring. It is thus essential to observe the 
preanalytical and analytical conditions for 
measurement to ensure the results are reliable. 
Aim  
1) To establish a level of awareness amongst 
pregnant women in terms of preparation for an 
oGTT, and compare the results of two waves 
of data collection. 
2) To identify the most frequent preanalytical 
mistakes made in connection with performing the 
oGTT, and compare the results of two waves 
of data collection. 
Methods 
Design 
Comparison of two cross-sectional studies. From 
2013–2017, two independent questionnaire studies 
were performed in the Olomouc and Zlín regions 
on a total of 477 pregnant women focused on quality 
of oGTT performance, and awareness and verification 
of the regime kept before and during the course 
of oGTT measurement. 
Sample 
The criteria determined for selecting respondents was: 
pregnant women in their 38th ± 2 week of pregnancy, 
who took oGTTs at selected sites in two regions of the 
Czech Republic who were willing to fill in 
a questionnaire. 
Data collection 
Information was ascertained using a non-standardised 
anonymous questionnaire. Once the management from 
each site gave their consent to the study, data 
collection began. The information was found using 
an anonymous nonstandardized questionnaire. Data 
collection began once the management of the relevant 
workplaces had given their consent with the study. 
Midwives were involved in the data collection for both 
studies. They handed out the questionnaires to 
pregnant women prior to cardiography examination 
(this examination is normally performed in the last 
stage of pregnancy), and asked them to fill it out. The 
filled-out questionnaires were then cast into prepared 
boxes in waiting rooms, and were picked up once 
a day by an authorized worker. 
Study 1 was undertaken in 2013–2014 (prior to 
unification of professional organisation guidelines), 
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and Study 2 was undertaken in 2016–2017 (following 
guidelines unification). Study 1 included 225 
respondents, while Study 2 included 252. A total of 
447 women were studied, with the remaining 80 
questionnaires eliminated for not meeting criteria (i.e., 
not all questionnaire items being completed, or not 
undergoing an oGTT in the second phase of the test).  
54% of those taking part in Study 1 were first-time 
mothers, 31% were second-time mothers and 15% 
third- or greater-time mothers. In Study 2, 58% of 
participants were first-time mothers, 30% were 
second-time mothers and 12% were third-time (or 
greater) mothers. More detailed information on 
respondents is given in Table 1. 
Table 1 Information on respondents (n = 477) 
Items Study 1: 2013–2014 
(n1 = 225) 
Study 2: 2016–2017 
(n2 = 252) 
 min. max. mean SD min. max. mean SD 
Descriptive statistics         
Mother’s age 16 43 31 5 14 44 31 5 
Week last oGTT performed 14 39 25 3 20 39 25 2 
Current week of pregnancy when questionnaire 
was filled in 
34 40 38 2 32 42 38 2 
Weight gain (in kg) during pregnancy 0 40 14 6 -9 30 13 5 
BMI at start of pregnancy 16 42 23 3 16 41 25 5 
BMI at end of pregnancy 18 43 27 4 18 43 28 4 
BMI – Body Mass Index; oGTT – oral glucose tolerance test; n1 – overall number of respondents in Study 1; n2 – overall number of respondents in Study 2; 




The IBM SPSS Version 24 software was used for 
statistical processing. The data acquired was assessed 
using descriptive statistics. We assessed the data 
descriptively, focusing on the substantive significance 
of the results (Soukup & Rabušic, 2007). Besides that, 
statistical inference was applied too. Tables 2 and 4 
show results of the chi-squared test, Table 3 then 
independent samples t-test results. 
In Study 1, the average BMI value at the beginning of 
pregnancy was 23, while in the 38th week it was 27. 
In Study 2 the average value of BMI was 25, and in 
the 38th week 28. 
Results 
Objective 1  
To establish a level of awareness in pregnant women 
of the regime prior to oGTT. 
The results regarding pregnant women’s awareness of 
the regime prior to performing oGTT are given in 
Table 2. 
Numbers (n) correspond to the number of women who 
gave a positive answer to the particular answer. 
Differences in terms of individual items range in value 
(from -12 to + 46 p.p.). Of these 5 items, a sum index 
of the women’s awareness was created from these five 
items ranging from 0–5 points – Table 3. 
Comparing the awareness of pregnant women from 
2013–2014 and 2016–2017, we can see that overall 
awareness had improved slightly by the second study, 
by a total of 8 percentage points. If we calculate the 
substantive significance of the results, Cohen’s 
d = 0.39, corresponding to a medium effect. Women 
are least aware of the reason for performing the oGTT, 
and the actual performance of the test in the 
laboratory. To a lesser extent, they lack information 
on possible side effects after taking the glucose 
solution, and have imprecise information on fasting.  
Objective 2 
Most frequent preanalytical mistakes made in 
connection with performing the oGTT. 
A summary of mistakes which respondents declared 
in oGTT testing is given in Table 4. 
As the table shows, results in the two years differed 
significantly, with changes between the two waves 
of data collection ranging from -69 p.p. to + 6 p.p. 
The vast majority of items saw a fall, implying 
an improvement in the situation. In the second wave 
of data collection, respondents declare many fewer 
mistakes in not observing the fasting period (-69 p.p.), 
followed by not observing the number of three 
samples (-65 p.p.), insufficient information given on 
recommended period of fasting prior to test (-46 p.p.), 
and inadmissible forms of glucose administration 
(-40 p.p.). 
Respondents also declared fewer errors in terms 
of performing the oGTT outside the period of the 
24th–28th week of pregnancy (-15 p.p.), not verifying 
the period of fasting and not smoking (-9 p.p.), 
performing the oGTT outside the sampling laboratory 
(-8 p.p.), not receiving results on site (-7 p.p.), not 
checking use of medication (-5 p.p.), taking sample 
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(n1 = 225) 
2: 2016–2017 
(n2 = 252)  
n % n % Sig. 
Awareness of diet prior to oGTT: 3 days prior to test keep 
standard dietary habits (no limitation to carbohydrate intake) 
70 31 86 34 3 0.495 
Awareness of fasting: period of 8–12 hours, no smoking 40 18 161 64 46 < 0.001 
Awareness of medication: regularly taken medication can only 
be taken after the test 
18 8 8 3 -5 0.026 
Awareness of reasons for performing oGTT 155 69 141 56 -12 0.005 
The woman subjectively has not missed any information on 
performing oGTT 
149 66 174 69 3 0.556 
oGTT – oral glucose tolerance test; n1 – overall number of respondents in Study 1; n2 = overall number of respondents in Study 2; n – number of responses; 
p.p. – percentage points; Sig. – statistical significance 
 
Table 3 Women’s awareness (sum index, 0–5 points) 
Items  Women’s awareness, sum index 0–5 points 
n mean min. max. SD Sig. 
Study 1 
Study 2 
2013–2014 225 1.94 0 4 0.98 < 0.001 
2016–2017 252 2.35 0 5 1.08 
n – number of respondents; min. – minimum; max. – maximum; SD – standard deviation; Sig. – statistical significance 
Table 4 Mistakes which respondents listed in performing the oGTT 
Faulty practices declared by respondents Study   
1: 2013–2014 
(n1 = 225) 
2: 2016–2017 
(n2 = 252) 
 
 
n % n % Difference (p.p.) Sig. 
Insufficiently informed about diet before undertaking 
the oGTT 
155 69 166 66 -3 0.495 
Insufficiently informed about recommended fasting 
period before the oGTT  
185 82 91 36 -46 < 0.001 
Insufficiently informed about use of medication before 
the oGTT 
207 92 244 97 5 0.026 
Respondent did not observe fasting period 182 81 30 12 -69 < 0.001 
oGTT performed outside sampling laboratory 38 17 23 9 -8 0.013 
Blood samples taken from capillary blood (from finger) 19 8 11 4 -4 0.088 
Number of 3 samples not observed (on empty stomach, 
after 1 h, after 2 h) 
180 80 38 15 -65 < 0.001 
Inadmissible form of glucose administration 122 54 35 14 -40 < 0.001 
Woman allowed free movement (outside laboratory) 
while undergoing oGTT 
45 20 66 26 6 0.129 
Exercise regime prior to oGTT not verified (question in 
laboratory) 
149 66 169 67 1 0.846 
Possibility of intercurrent disease not ascertained 
(question in laboratory) 
191 85 204 81 -3 0.275 
Period of fasting and not smoking not verified 
(question in laboratory) 
205 91 207 82 -9 0.005 
Use of medication not verified (question in laboratory) 200 89 212 84 -5 0.143 
oGTT performed outside 24th–28th week 56 25 25 10 -15 < 0.001 
oGTT results not received on site 41 18 27 11 -7 0.025 
n1 – overall number of respondents in Study 1; n2 = overall number of respondents in Study 2; n – number of responses; p.p. – percentage points; Sig. – statistical 
significance 
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from capillary blood (-4 p.p.), being insufficiently 
informed of diet before undertaking oGTT (-3 p.p.), 
and not checking the possibility of intercurrent disease 
(-3 p.p.). 
There was a slight worsening in some mistakes. More 
respondents declared errors regarding not verifying 
their exercise regime before oGTT (+ 1 p.p.), being 
insufficiently informed on medication use prior to the 
oGTT (+ 5 p.p.) and free movement of the woman 
outside the laboratory being allowed while undergoing 
the oGTT (+ 6 p.p.). Although the vast majority 
of items (12 of 15) saw an improvement, many 
mistakes continued to be made, as declared by most 
respondents. Very common mistakes listed in the 
second wave of data collection are not checking 
medication use (84%), not checking the period 
of fasting and not smoking (82%), not checking the 
possibility of an intercurrent disease (81%), and also 
being insufficiently informed of what diet to observe 
prior to undertaking the oGTT (66%). 
Discussion 
The inconsistent approach to GDM diagnosis around 
the world has led to intensive efforts to implement 
uniform rules. There have also been worries, however, 
that this would lead to a large increase in proven GDM 
cases (Krejčí et al., 2014; Visser & de Valk, 2013).  
In a study by Franeková and Jabor (2010), GDM was 
ascertained at rates of 9.6%–24%, while a study by 
Anderlová et al. (2014a) found it amongst 16%–24.5% 
of pregnant women. The difference was whether blood 
sugar levels were also taken after 60 minutes. 
An epidemiological study by Krejčí et al. (2019) using 
the new criteria (2016–2018) recorded GDM amongst 
14.5% of women. GDM rates increased significantly 
with an age of over 30 years. In Study 1, we found 
positive oGTT results (i.e. GDM) for 10% of pregnant 
women, and in Study 2 we found it for 12% of women. 
It is well known that around 70%–80% of women with 
GDM are overweight or obese (Andělová, 2013).  
Delaying pregnancy to a later age, poor diet, being 
overweight and obese linked to insulin resistance are 
major risk factors, as is too much weight gain during 
pregnancy (Anderlová et al., 2014b; Krejčí, 2016; 
Krejčí et al., 2019). Both our studies found an average 
age of first-time mothers of 31 years. In Study 1, the 
BMI for women with GDM at the start of pregnancy 
was 23.50 ± 3.60 (within the norm), while the figure 
in Study 2 was 25.08 ± 4.93 (overweight). A large 
increase in the weight of mothers during pregnancy 
has also been shown to have an impact in terms of their 
children being overweight (Svačina, 2013). As such, it 
is recommended that overweight women carefully 
monitor their weight gain during pregnancy. 
Although the quality of oGTT implementation has 
improved in recent years, we still encounter a number 
of faulty procedures in practice. We have summarised 
the faults we ascertained through the questionnaire in 
Table 4. oGTT performed outside 24th–28th week was 
found in 56 cases in Study 1 (i.e., 25%), and in 25 
cases in Study 2 (i.e., 10%). Tests performed prior to 
the 24th week may lead to GDM being undiagnosed. 
An oGTT performed too late can result in late 
discovery, and thus late GDM treatment. In our study, 
4% of respondents stated that their blood sample 
was taken from their finger, which is incorrect. 
While under normal circumstances, blood sugar level 
in capillary and venous blood will be the same, 
following glucose application the difference comes to 
20%–25%. Determining blood sugar level using 
a glucometer is only suitable for general testing 
of glycaemic profile amongst diabetics, but not for 
diagnosing GDM. If venous blood samples are taken 
in the doctor’s surgery and only then sent to the 
laboratory, there is a danger of an incorrect result due 
to the time delay involved. The correct procedure for 
performing and assessing an oGTT is given in the 
recommended procedure (Andělová et al., 2015, 
2018). 
On the basis of our investigation, we can say that 
implementation of the common guidelines has led to 
an improvement in oGTT performance. In terms of the 
quality of the information (Tables 2 and 3) and 
verification of the recommended regime for mothers 
prior to oGTT (Table 4), however, significant room for 
improvement was found. Workers in the sampling 
laboratory do not sufficiently check (in up to 80% of 
cases) whether the recommended regime prior to the 
test was observed, and they rely on the fact that the 
pregnant woman has been instructed by their referring 
gynaecologist.  
Also frequently not observed was the physical 
inactivity of pregnant women during the course of the 
test. Physical activity can skew the results of the test, 
which can then be “falsely within the norm”.  
If a standard oGTT cannot be performed due to 
vomiting, it is recommended that it be replaced at least 
with a blood sugar level test on an empty stomach, and 
determination of postprandial blood sugar level 
following a breakfast including at least 50 g of 
carbohydrates. This value should be lower than 
7.8 mmol/l (Krejčí, 2016).  
Krejčí stresses that in order to minimise errors in 
performing an oGTT, the pregnant woman must be 
given the correct information, samples should be taken 
directly in the laboratory, and blood sugar levels 
should be measured using the standard laboratory 
method (Krejčí, 2016). 
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Women should be informed of the recommended 
period of fasting (8–12 hours) prior to collection. 
Fasting for over 12 hours is inappropriate, and fasting 
for less than 8 hours is insufficient (Krejčí, 2016). 
In our study, we ascertained that women were often 
given imprecise, or even no, information. Study 2 saw 
an improvement in awareness of the period of fasting 
prior to the oGTT. Awareness increased from 18% to 
64%, although this still means that the remaining 36% 
of pregnant women were given insufficient 
information. Also, 34% of respondents said that they 
were not informed of unrestricted sugar 
(carbohydrate) intake 3 days prior to the test. 
In a short questionnaire survey undertaken by 
Bankovic Radovanovic and Kocijancic in 23 Croatian 
primary and secondary medical facilities of 343 
respondents prior to an oGTT test, it was found that 
42% of respondents had a high level of knowledge of 
how the oGTT was performed, and 38% had an 
appropriate level of knowledge. The level of 
knowledge was lower amongst pregnant women who 
received information from their gynaecologist 
compared to women who received information 
from laboratory staff (Bankovic Radovanovic 
& Kocijancic, 2015). 
GDM treatment involves dietary regulation, lifestyle 
modification, and regular blood sugar level tests. 
Relatively few pregnant women with GDM require 
insulin therapy. Complications can be prevented by 
catching GDM early, correctly determining 
a diagnosis, and receiving optimal follow-up 
treatment (Calkins & Devaskar, 2011; Catalano et al., 
2012; Marshall et al., 2014; Schneider et al., 2011). 
Limitation of study 
Both comparative studies involve intentional selection 
of respondents on the basis of predetermined criteria, 
which regardless of its size cannot be considered 
representative considering the population 
investigated. As such, the results obtained cannot be 
generalised, although one can focus on the substantive 
significance of the results, which is no less important 
for practice. Statistical inference was applied within 
our analysis based on the request made by the editors 
of the magazine. However, we need to mention the 
fact that there are articles that warn of its limitations 
when applied in scientific discourse in both the Czech 
Republic (Soukup & Rabušic, 2007; Soukup, 2010; 
Soukup & Kočvarová, 2016) and abroad (Bernardi 
et al., 2017).  
In the second study implemented in 2016–2017, the 
same respondents could not be involved, because 
during the period the investigation was implemented, 
they had to be pregnant women who had the oGTT 
ahead of them. The compared selections, however, 
show very similar characteristics (see Table 1). At the 
same time, it was not possible to ensure that responses 
related to the same staff performing the test as had 
been the case in the previous study. From this 
perspective, too, one should consider a comparison 
of results as indicative, and results cannot be broadly 
generalised. Many identified differences are 
significant, and certainly tell us that we need to 
continue to focus on the issue investigated, which 
if overlooked could have unfortunate consequences 
in practice. 
Conclusion 
The unified recommended GDM screening procedure 
in the Czech Republic has had a positive impact on the 
validity of investigations undertaken in certified 
laboratories. The awareness of pregnant women about 
preparing for the oGTT, however, has only improved 
a little. It is thus essential to increase women’s 
awareness of how to prepare correctly prior to the 
performance of the laboratory test. We are therefore 
putting together educational materials for 
gynaecological surgeries and sampling laboratories. 
These comprise information leaflets which should 
improve pregnant women’s awareness, thus helping 
improve the precision of oGTT results and ensure 
correct GDM diagnosis. 
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